SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016A translational modelling and simulations approach to exploit pre-clinical tuberculosis data | S. WichaView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016The relationship between pyrazinamide pharmacokinetics (PK) and microbiologic outcomes in patients with pulmonary TB receiving standard- or high-dose rifampicin: PK/PD results from TBTC trials 27 and 28 and PanACEA MAMS | K. DooleyView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Application Of A Multi-Compartment Permeability-Limited Lung Model To Predict Lung Concentrations Of Moxifloxacin In Virtual Human Subjects | O. HatleyView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Development of a novel multi-compartment granuloma model to predict local drug distribution and its impact on pharmacodynamics and disease progression in tuberculosis. | I. GardnerView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Lost in translation: learning from preclinical data | Gerry DaviesView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016A Need for altering Tuberculosis Dosing Regiments for patients with HIV-associated Tuberculous Meningitis | G. AljayyoussiView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Sub-therapeutic concentrations of anti-tuberculosis drugs in children when treated according to indian dosing recommendation | B. GuiastrennecView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Early interventions for diabetes related tuberculosis hasten sputum microbiological clearance in Virginia, USA | S. HeysellView Slideset
CPCharles PeloquinPharmDSlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Charles Peloquin, PharmDView Slideset
SlidesetTuberculosisInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016Lung Tissue Concentrations of Pyrazinamide among Patients with Tuberculosis | R. KempkerView Slideset
VideoViral Hepatitis and Liver DiseaseSymposium on Key Issues in Liver Transplantation for NASH 2016What is an acceptable BMI | Lee Kaplan, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseSymposium on Key Issues in Liver Transplantation for NASH 2016Role of Bariatric Surgery - Pre-, During or Post-Transplant | Julie Heimbachx, MDView Video
